BioSpace News Archive

Junshi Biosciences announced that the United States Food and Drug Administration has expanded the emergency use authorization for etesevimab and bamlanivimab administered together to include certain high-risk pediatric patients from birth to under 12 years old for the treatment of mild to moderate COVID-19 as well as post-exposure prophylaxis, according to Eli Lilly and Company, the company’s global partner.

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, provided new analyses from the landmark DREAM-HF Phase 3 trial showing that the greatest treatment benefit from rexlemestrocel-L is in HFrEF patients with diabetes and/or ischemia, who are at high-risk of cardiovascular mortality, heart attacks or strokes.

Immune-mediated inflammatory disease (IMID) is a group of unrelated conditions that lack a definitive etiology, but share a common inflammatory pathway leading to inflammation.

Catheter-related bloodstream infections occur due to presence of bacteremia. It is one of the most frequent, lethal, and costly complications of central venous catheterization and the most common cause of nosocomial bacteremia.

Dialyzer is a type of medical device which helps in replacing the kidney function through removing metabolic waste products and excess water from the blood.

Fact.MR – A Market Research and Competitive Intelligence Provider: Sales of animal parasiticides are forecast to grow at a steady 5.9% between 2020 and 2026, as per a market survey by Fact.MR.

Rising number of surgical procedure in the hospitals and clinics likely to influence demand for the global market for hospital gowns market in coming years.

Increasing importance of education in the healthcare industry to address organizational challenges and deliver improved care has led to the merger of healthcare, technology and digital solution providers to develop healthcare education solutions.

Dandy-Walker Syndrome involves the partial or complete absence of the area of the brain between the two cerebellar hemispheres, and a cyst formation near the lowest part of the skull.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global anti-snoring devices and snoring surgery market is expected to expand at a 7.2% CAGR, reaching US$ 40 Bn by 2031.